Upcoming Events

Join STAT writers Adam Feuerstein, Damian Garde, Kate Sheridan, and Matt Herper for an event on the future of biotech as we enter 2020. They’ll sit down with industry leaders to discuss the trends you should be watching out on the eve of this new decade. Together, we’ll map out the year to come, starting with what to expect at the J.P Morgan Healthcare Conference in January. STAT Plus subscribers can register for free as part of their subscription, and non-subscribers can purchase a ticket.

Register now

Genomics Live is Europe’s leading conference designed to deliver diagnostics and precision medicine into the clinic. The event will cover areas including: Digital Pathology, Molecular Diagnostics, Flow Cytometery, CT DNA, Single Cell Analysis, Companion Diagnostics, Precision Medicine, and Biobanking. Genomics Live brings together pharmaceutical companies, health care, academia, and government officials to provide the best possible grounding topics to launch tomorrow’s technologies into the clinic in the fastest way.

Register now

Returning for its 25th year, Pri-Med East is a continuing medical education (CME/CE) experience on Wednesday−Saturday, December 4−7, in Boston, MA, that will gather thousands of primary care clinicians from across the northeast. The conference features inspiring keynote speakers, including Massachusetts Governor Charlie Baker, and a brand-new curriculum with nearly 60 educational sessions driven by the latest clinical guidelines and recommendations. Clinicians can earn up to 23 CME/CE credits.

Register now

McKinsey & Company is seeking Early Stage ventures to apply for an opportunity to present a short presentation in front of investors, potential partners, interested investors, or industry players to pre-register for the event. The ESIC presents a unique opportunity for the 40+ presenting start-ups to connect with peers, investors, and industry leaders. Applications are due November 15th, 2019.

Register now

DYK: Drug-resistant superbugs are as a big of a threat to the human population as climate change.

In 1928, Alexander Fleming, discovered penicilin, the first true antibiotic. Since then, doctors have prescribed antibiotics to patients to treat infections that were caused by bacteria. Until now, infections such as pneumonia were considered straightforward to treat — a course of antibiotics, and you would usually be on your way back to health.

70 years of consuming antibiotics, as well as over-prescription of antibiotics to patients to treat infectious diseases, have created an antimicrobial resistance, which begs the question — how can you fight an infection when antibiotics are no longer effective?

In 2016, 490,000 people developed multi-drug resistant tuberculosis globally, and drug resistance is starting to complicate the fight against HIV and malaria. Microorganisms are changing to adapt to antimicrobial drugs, and develop antimicrobial resistance, also referred to as ‘superbugs’.

Join JLABS Boston on December 9th to learn from the experts on how antimicrobial resistance is threatening our ability to treat common infectious diseases, the implications on our healthcare system, and how companies in this space are working to create future treatments.

Register now

Emerging technological innovations enabled by next generation sensors will define the landscape for the future commercialization of life changing products. The exponential growth of the global sensors market and the demand for next generation integrated systems is expected to reach over $150 billion by 2025. Cambridge Healthcare Institute’s International faculty of key industry and academic leaders will present the latest technological advancements of real-world applications within healthcare, manufacturing, and emerging markets through featured plenary talks, conference tracks, tutorials, and roundtable discussions.

Register now

Actionable Strategies for Drug and Medical Device Products Liability Litigators and In-house Counsel

Get 10% off with STAT Plus code: D10-710-710DX02

ACI’s Drug and Medical Device Litigation conference is the only event which brings together an exceptional in-house presence on the faculty, the top defense firms representing pharmaceutical and medical device companies, experienced jurists from around the country, the FDA, and the DOJ. Designed for both networking and masters-level strategy sharing, this is the leading forum at which to learn winning life sciences products liability litigation strategies.

Attendees of this event will benefit from exclusive, intimate and interactive think tanks aimed at promoting the advancement of your products liability practice.

Register now

Individuals and teams drive innovation throughout the biomedical industry, from discovery research to clinical trials, product development and the larger market. Because of the risks inherent in this process, there is great interest in cultivating individual and team behaviors to try to make innovation more systematic.

In this webinar, Jeff Karp, PhD, will draw upon his history of bridging academia and industry, starting six companies (including the newly public Frequency Therapeutics), creating multiple products and raising more than $300 million dollars in venture and philanthropic funding. He will discuss ways to encourage creativity and individual empowerment in your team, and utilize your network to efficiently socialize ideas, and identify strategic priorities.

Register now